The company's board meeting is also set, which will not only approve the standalone and consolidated earnings but also ...

The Indianapolis-based drugmaker said the supercomputer will power an "AI factory" designed to accelerate drug discovery and development.

The London Company reviews Q3 Mid Cap results, citing quality headwinds and top stock drivers like SGI and NEU. See how their ...

The London Company reviews Q3 Mid Cap strategy vs. Russell Midcap, spotlighting long-term outperformance. See how disciplined ...

Vanigent BioPharm has launched Vanitrack, an AI-powered platform that combines compliance and expense management for ...

Eli Lilly partners with Nvidia to build the pharma industry’s most powerful AI supercomputer, aiming to speed up drug discovery and innovation.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.

We've all seen them: 30-second television ads from attorneys, targeting those who've had a negative side effect after using a ...

Insurers weigh potential ripple effects from a case testing product liability, regulatory authority, and the line between ...

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...